Quantum Biopharma (QNTM) Share-based Compensation (QoQ) (2020 - 2026)
Quantum Biopharma (QNTM) Share-based Compensation (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Quantum Biopharma | 2.61 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.34% |
| Dec 31, 2025 | -18.85% |
| Sep 30, 2025 | 17.26% |
| Jun 30, 2025 | 191.68% |
| Mar 31, 2025 | 453.16% |
| Dec 31, 2024 | -226.07% |
| Sep 30, 2024 | -41.34% |
| Jun 30, 2024 | 93.14% |
| Mar 31, 2024 | -41.90% |
| Dec 31, 2023 | -21.23% |
| Sep 30, 2023 | -68.72% |
| Jun 30, 2023 | -87.42% |
| Mar 31, 2023 | 532.97% |
| Dec 31, 2022 | -13.63% |
| Sep 30, 2022 | 65.21% |
| Jun 30, 2022 | 326.89% |
| Mar 31, 2022 | -75.65% |
| Dec 31, 2021 | 37.07% |
| Sep 30, 2021 | -91.75% |
| Jun 30, 2021 | -21.18% |